Author:
Doñate F,Juarez J C,Burnett M E,Manuia M M,Guan X,Shaw D E,Smith E L P,Timucin C,Braunstein M J,Batuman O A,Mazar A P
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Berenson JR, Boccia RV, Bashey A, Levine AM, Koc ON, Callahan JA, Mazar AP, Reich SD (2006) Phase I study of the [Cu, Zn] superoxide dismutase (SOD1) inhibitor ATN-224 (Bis-choline tetrathiomolybdate) in patients (pts) with advanced hematologic malignancies. Blood (ASH Annual Meeting Abstracts) 108. Abstracts 2593
2. Bertolini F, Shaked Y, Mancuso P, Kerbel RS (2006) The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer 6: 835–845
3. Bhatt RS, Seth P, Sukhatme VP (2007) Biomarkers for monitoring antiangiogenic therapy. Clin Cancer Res 15: 777s–780s
4. Brewer GJ, Dick RD, Grover DK, LeClaire V, Tseng M, Wicha M, Pienta K, Redman BG, Jahan T, Sondak VK, Strawderman M, LeCarpentier G, Merajver SD (2000) Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: phase I study. Clin Cancer Res 6: 1–10
5. Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438: 932–936
Cited by
64 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献